CEO Christopher Reedy undergoing new medical treatment while remaining in role
Butler National CEO Christopher Reedy announced he is undergoing a new course of medical treatment following Mayo Clinic consultations related to his 2019 cancer diagnosis. Reedy stated he will continue serving as CEO despite periodic absences, with the company expressing confidence in its leadership team and business momentum.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day